Medpace is ready to help you with your next clinical trial project. Find out more about how we can help. GO NOW
2012
Medpace, Inc. acquires MediTech Strategic Consultants B.V., a European-based Contract Research Organization (CRO) Specializing in Medical Device
Medpace completes relocation of Medpace Reference Laboratories (MRL), doubling Medpace central laboratory capacity
Medpace completes construction on a new Clinical Pharmacology Unit - expanding Phase I-IIa clinical research capabilities
Medpace, Inc. hits 20 year mark as a full service, global CRO
"First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites" by Marc Salzberg, MD
Medpace announces the addition of Cheri Lindberg, MD, Medical Director, strengthening Medpace’s Therapeutic and Regulatory Expertise in Psychiatry
Medpace CEO and Founder, August J. Troendle, MD, accepts the Lifetime Achievement Award for Innovation from the Cincinnati USA Regional Chamber
Medpace welcomes Piotr Krzeski, MD, PhD, MFPM, Medical Director adding expertise in Gastroenterology
Medpace opens office in Lyon, France
Medpace announces the addition of Jason D. Hurt, MD, Medical Director, strengthening Medpace Therapeutic Expertise in Gynecologic Oncology
2011
Medpace strengthens European leadership and widens presence in Europe, opening two new offices in Scotland and Italy
Medpace Medical Device (MMD) announces the addition of Mike Winegar as Vice President, Regulatory Affairs
Medpace announces plans to enter into an equity recapitalization with affiliates of CCMP Capital Advisors, LLC
Medpace announces the addition of Brian Murphy, MD, MPH, Medical Director, strengthening Medpace’s Therapeutic Expertise in Infectious Disease and Pediatric Drug Development.
Medpace announces the addition of Dr. Jon Bruss, Medical Director, adding therapeutic expertise in infectious disease, antibiotics, anti-virals, vaccines, and pediatric medicines.
2010
Symbios Clinical, a medical device CRO and subsidiary of Medpace Inc., changes name to Medpace Medical Device, concluding integration activities
Medpace Reference Laboratories (MRL) central labs in China and India achieve CAP Accreditation, NGSP Level 1 and CDC Lipid Standardization Part III standardization, completing the company’s ability to deliver global, identical, highly standardized laboratory services in its own facilities
Medpace, Inc. acquires Symbios Clinical, a US-based Clinical Research Organization (CRO) Specializing in Medical Device Trials
Medpace Executive Director David G. Orloff, MD, to co-chair Educational Satellite Symposia, New Frontiers in Anti-Atherosclerotic Therapies
Medpace announces the addition of Samer E. Kaba, MD, Medical Director, strengthening therapeutic expertise in neuroscience drug development services
Medpace Medical Director, Jim Wei, MD, PhD to present at the Outsourcing Clinical Trials Conference, January 27-28, 2010
Medpace, Inc. continues their European expansion with the acquisition of Medical Consulting Dr. Schlichtiger GmbH
Medpace Sets Groundbreaking for Global Headquarters in Madisonville